Arnon Nagler, MD
Chaim Sheba Medical Center
12
12
6
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (12)
Showing 10 of 12 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Leo I Gordon, MD
Northwestern University
Shared therapeutic areas:
Worked with same sponsors:
Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Shared therapeutic areas:
Sarit Assouline, MD
McGill University - Jewish General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Philipp le Coutre, MD
Charité University of Berlin
Shared therapeutic areas:
Worked with same sponsors:
Bruno Martino, MD
A.O. Bianchi-Melacrino-Morelli
Shared therapeutic areas:
Worked with same sponsors:
Elisabetta Abruzzese, MD
Università di Tor Vergata Ospedale di S. Eugenio
Shared therapeutic areas:
Worked with same sponsors:
Luca Arcaini, MD
IRCCS Policlinico San Matteo Pavia
Shared therapeutic areas:
Worked with same sponsors:
Marcio Andrade, MD
Hospital Miguel Servet
Shared therapeutic areas:
Worked with same sponsors:
Carlo Gambacorti-Passerini, MD
Azienda Ospedaliera San Gerardo di Monza
Shared therapeutic areas:
Worked with same sponsors:
Alessandra Iurlo, MD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (12)
Showing 12 of 12 trials
Lonquek for Autologous Stem Cell Mobilization
Treosulfan-based Conditioning for Transplantation in AML/MDS
CT-011 MAb in DLBCL Patients Following ASCT
Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients
Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Mozobil for Autologous Stem Cell Mobilization
Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB)
TevaGastrim for Stem Cell Mobilization Sibling Donors
Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients
Carfilzomib for the Prevention of Graft Versus Host Disease
Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia
Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
All 12 trials loaded